Literature DB >> 21811097

Function of ERBB4 is determined by alternative splicing.

Ville Veikkolainen1, Katri Vaparanta, Kalle Halkilahti, Kristiina Iljin, Maria Sundvall, Klaus Elenius.   

Abstract

Alternative splicing is a central tool  of evolution that significantly increases the size of transcriptomes and generates functional specification. Within the human ERBB receptor gene family, only ERBB4 is known to produce functionally distinct isoforms as a result of alternative splicing. While ErbB4 signaling has been demonstrated to regulate cellular processes involved in embryogenesis, carcinogenesis and cardiovascular and psychiatric diseases, relatively little is known about the contribution of the individual isoforms in the different biological contexts. Here, we review recent findings as well as provide novel data about the distribution and functions of the ERBB4 splice variants. These observations represent an example of how minor alterations in the transcripts of a single gene can result in even antagonistic cellular responses. The observations also underline the significance of understanding the unique functions of isoforms of a potential drug target gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21811097     DOI: 10.4161/cc.10.16.17194

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  59 in total

Review 1.  The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.

Authors:  Brian Wadugu; Bernhard Kühn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 2.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

3.  Local delivery of the Neuregulin1 receptor ecto-domain (ecto-ErbB4) has a positive effect on regenerated nerve fiber maturation.

Authors:  G Gambarotta; D Pascal; G Ronchi; M Morano; S B Jager; S Moimas; L Zentilin; M Giacca; I Perroteau; P Tos; S Geuna; S Raimondo
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

Review 4.  Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines.

Authors:  Cecilia Vasti; Cecilia M Hertig
Journal:  World J Cardiol       Date:  2014-07-26

5.  Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.

Authors:  Andrew J Streets; Tajdida A Magayr; Linghong Huang; Laura Vergoz; Sandro Rossetti; Roslyn J Simms; Peter C Harris; Dorien J M Peters; Albert C M Ong
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-11

6.  Developmental pruning of excitatory synaptic inputs to parvalbumin interneurons in monkey prefrontal cortex.

Authors:  Daniel W Chung; Zachary P Wills; Kenneth N Fish; David A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-10       Impact factor: 11.205

Review 7.  Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.

Authors:  Miranda L Fisher; Anu Loukola; Jaakko Kaprio; Jill R Turner
Journal:  Int Rev Neurobiol       Date:  2015-09-16       Impact factor: 3.230

8.  Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo.

Authors:  Jessica K Bernard; Sean P McCann; Vrinda Bhardwaj; Mary K Washington; Mark R Frey
Journal:  J Biol Chem       Date:  2012-10-02       Impact factor: 5.157

9.  Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.

Authors:  Jonathan W Haskins; Don X Nguyen; David F Stern
Journal:  Sci Signal       Date:  2014-12-09       Impact factor: 8.192

10.  Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland.

Authors:  Ilkka Paatero; Tiffany N Seagroves; Katri Vaparanta; Wen Han; Frank E Jones; Randall S Johnson; Klaus Elenius
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.